Epidemiological and Clinical Characterization of Superinfections in Critically Ill Coronavirus Disease 2019 Patients
Overview
Authors
Affiliations
Design: Retrospective analysis of prospectively collected observational data.
Setting: University-affiliated adult ICU.
Patients: Ninety-two coronavirus disease 2019 patients admitted to the ICU from February 21, 2020, to May 6, 2020.
Interventions: None.
Measurements And Main Results: The prevalence of superinfection at ICU admission was 21.7%, and 53 patients (57.6%) had at least one superinfection during ICU stay, with a total of 75 (82%) ventilator-associated pneumonia and 57 (62%) systemic infections. The most common pathogens responsible for ventilator-associated pneumonia were ( = 26, 34.7%) and ( = 14, 18.7%). Bloodstream infection occurred in 16 cases, including methicillin-resistant ( = 8, 14.0%), species ( = 6, 10.5%), and species ( = 2, 3.5%). Fungal infections occurred in 41 cases, including 36 probable (30 by , six by ) and five proven invasive candidiasis (three , two ). Presence of bacterial infections (odds ratio, 10.53; 95% CI, 2.31-63.42; = 0.005), age (odds ratio, 1.17; 95% CI, 1.07-1.31; = 0.001), and the highest Sequential Organ Failure Assessment score (odds ratio, 1.27; 95% CI, 1.06-1.63; = 0.032) were independently associated with ICU or 28-day mortality.
Conclusions: Prevalence of superinfections in coronavirus disease 2019 patients requiring mechanical ventilation was high in this series, and bacterial superinfections were independently associated with ICU or 28-day mortality (whichever comes first).
Zuniga-Moya J, Papadopoulos B, Mansoor A, Mazi P, Rauseo A, Spec A Open Forum Infect Dis. 2024; 11(4):ofae108.
PMID: 38567199 PMC: 10986750. DOI: 10.1093/ofid/ofae108.
Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis.
Langford B, So M, Simeonova M, Leung V, Lo J, Kan T Lancet Microbe. 2023; 4(3):e179-e191.
PMID: 36736332 PMC: 9889096. DOI: 10.1016/S2666-5247(22)00355-X.
Kovacevic P, Topolovac S, Dragic S, Jandric M, Momcicevic D, Zlojutro B Medicina (Kaunas). 2022; 58(12).
PMID: 36556932 PMC: 9781202. DOI: 10.3390/medicina58121730.
Novacescu A, Buzzi B, Bedreag O, Papurica M, Rogobete A, Sandesc D Infect Drug Resist. 2022; 15:7001-7014.
PMID: 36478964 PMC: 9721122. DOI: 10.2147/IDR.S390681.
Ruiz-Santana S, Mora-Quintero M, Saavedra P, Montiel-Gonzalez R, Sanchez-Ramirez C, Perez-Acosta G Antibiotics (Basel). 2022; 11(8).
PMID: 36009884 PMC: 9405068. DOI: 10.3390/antibiotics11081016.